Rewriting the script: gene therapy and genome editing for von Willebrand Disease
In recent years gene therapy has emerged as a powerful technology for treatment of a large variety of inherited disorders. With the FDA approval of in vivo gene therapy of hemophilia A and B using AAV-mediated transgene delivery to hepatocytes, the path towards a new treatment era seemed paved. Also...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2025-09-01
|
| Серии: | Frontiers in Genome Editing |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fgeed.2025.1620438/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|